Targeting NQO1/GPX4-mediated ferroptosis by plumbagin suppresses in vitro and in vivo glioma growth

1,4-Naphthoquinones: Some Biological Properties and Application

(2020) Dmitry Aminin et al.   CHEMICAL & PHARMACEUTICAL BULLETIN

Nrf2 and Ferroptosis: A New Research Direction for Neurodegenerative Diseases

(2020) Xiaohua Song et al.   Frontiers in Neuroscience

Antitumor Effects and the Compatibility Mechanisms of Herb Pair Scleromitrion diffusum (Willd.) R. J. Wang–Sculellaria barbata D. Don

(2020) Li Lu et al.   Frontiers in Pharmacology

Pharmacological targets and molecular mechanisms of plumbagin to treat colorectal cancer: A systematic pharmacology study

(2020) Yujia Liang et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Ferroptosis and Cancer: Mitochondria Meet the “Iron Maiden” Cell Death

(2020) Anna Martina Battaglia et al.   Cells

A Potential Mechanism of Temozolomide Resistance in Glioma–Ferroptosis

(2020) Zhifang Hu et al.   Frontiers in Oncology

A comprehensive review on β-lapachone: Mechanisms, structural modifications, and therapeutic potentials

(2020) Qijie Gong et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Chaperone-mediated autophagy is involved in the execution of ferroptosis

(2019) Zheming Wu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial

(2019) Ulrich Herrlinger et al.   LANCET

A GPX4-dependent cancer cell state underlies the clear-cell morphology and confers sensitivity to ferroptosis

(2019) Yilong Zou et al.   Nature Communications

NQO1 targeting prodrug triggers innate sensing to overcome checkpoint blockade resistance

(2019) Xiaoguang Li et al.   Nature Communications

Synthesis and Evaluations of Novel Apocynin Derivatives as Anti-Glioma Agents

(2019) Tao Yang et al.   Frontiers in Pharmacology

FSP1 is a glutathione-independent ferroptosis suppressor

(2019) Sebastian Doll et al.   NATURE

The chemical basis of ferroptosis

(2019) Marcus Conrad et al.   Nature Chemical Biology

NAD(P)H:Quinone Oxidoreductase 1 (NQO1) as a Therapeutic and Diagnostic Target in Cancer

(2018) Kuojun Zhang et al.   JOURNAL OF MEDICINAL CHEMISTRY

Plumbagin inhibits the proliferation and survival of esophageal cancer cells by blocking STAT3-PLK1-AKT signaling

(2018) Ying-Ya Cao et al.   Cell Death & Disease

Quantitative Analysis of the Global Proteome in Peripheral Blood Mononuclear Cells from Patients with New-Onset Psoriasis

(2018) Fengdi Li et al.   PROTEOMICS

Ferroptosis and Its Role in Diverse Brain Diseases

(2018) Abigail Weiland et al.   MOLECULAR NEUROBIOLOGY

Cytotoxic naphthoquinones from Arnebia densiflora (Nordm.) Ledeb and determining new apoptosis inducers

(2018) Merve Yuzbasioglu Baran et al.   NATURAL PRODUCT RESEARCH

PharmMapper 2017 update: a web server for potential drug target identification with a comprehensive target pharmacophore database

(2017) Xia Wang et al.   NUCLEIC ACIDS RESEARCH

Deferiprone Enhances Temozolomide Cytotoxicity in Glioma Cells

(2016) George A. Alexiou et al.   CANCER INVESTIGATION

Inhibitory effects of lapachol on rat C6 glioma in vitro and in vivo by targeting DNA topoisomerase I and topoisomerase II

(2016) Huanli Xu et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

New naphthoquinone derivatives against glioma cells

(2015) Marco Redaelli et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Regulation of Ferroptotic Cancer Cell Death by GPX4

(2014) Wan Seok Yang et al.   CELL

Thioredoxin-like 2 regulates human cancer cell growth and metastasis via redox homeostasis and NF-κB signaling

(2010) Ying Qu et al.   JOURNAL OF CLINICAL INVESTIGATION